Page last updated: 2024-08-17

edetic acid and Apoplexy

edetic acid has been researched along with Apoplexy in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's8 (66.67)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Aakerøy, R; Ellekjær, H; Hegstad, S; Helland, A; Kristoffersen, AH; Schjøtt, J; Spigset, O; Stokes, CL; Tomić, M1
Dagres, N; Dan, GA; Ekart, R; Ferro, C; Lenarczyk, R; Lip, GYH; Mallamaci, F; Ortiz, A; Potpara, TS; Sarafidis, P1
Dans, AL; Forster, R; Sulit, DV; Tan, FN; Villarruz-Sulit, MV1
Calderon Moreno, R; Diaz, D; Escolar, E; Fonseca, V; Lamas, GA; Nathan, DM; Navas-Acien, A; Newman, J; Schmedtje, JF1
Boineau, R; Drisko, J; Goertz, C; Lamas, GA; Lee, KL; Lewis, EF; Lindblad, L; Mark, DB; Nahin, RL; Rozema, T1
Bauchner, H; Fontanarosa, PB; Golub, RM1
Nissen, SE1
Bittl, JA1
Kleinman, B1
Lamas, GA; Lee, KL; Mark, D1
Noto, B; Rahbar, K; Schäfers, M; Stegger, L; Vrachimis, A1
Dichgans, M; Gschwendtner, A; Hamann, G; Lõhmussaar, E; Meitinger, T; Mueller, JC; Org, T; Wichmann, E1

Reviews

2 review(s) available for edetic acid and Apoplexy

ArticleYear
Chelation therapy for atherosclerotic cardiovascular disease.
    The Cochrane database of systematic reviews, 2020, 05-05, Volume: 5

    Topics: Angina Pectoris; Arteriosclerosis; Cause of Death; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Stroke

2020
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    The Journal of clinical endocrinology and metabolism, 2019, 07-01, Volume: 104, Issue:7

    Topics: Antioxidants; Arsenic; Ascorbic Acid; Atherosclerosis; Cadmium; Calcium Chelating Agents; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Copper; Diabetes Complications; Diabetes Mellitus; Edetic Acid; Glycation End Products, Advanced; Hospitalization; Humans; Iron; Lead; Lipid Metabolism; Mercury; Myocardial Infarction; Myocardial Revascularization; Oxidative Stress; Randomized Controlled Trials as Topic; Stroke

2019

Trials

1 trial(s) available for edetic acid and Apoplexy

ArticleYear
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.
    JAMA, 2013, Mar-27, Volume: 309, Issue:12

    Topics: Aged; Angina Pectoris; Atherosclerosis; Chelating Agents; Double-Blind Method; Edetic Acid; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Recurrence; Risk; Stroke; Treatment Outcome

2013

Other Studies

9 other study(ies) available for edetic acid and Apoplexy

ArticleYear
Serum or Plasma for Quantification of Direct Oral Anticoagulants?
    Therapeutic drug monitoring, 2022, 08-01, Volume: 44, Issue:4

    Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Citrates; Dabigatran; Edetic Acid; Factor X; Humans; Pyridones; Rivaroxaban; Stroke

2022
Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based su
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2020, 03-01, Volume: 22, Issue:3

    Topics: Anticoagulants; Atrial Fibrillation; Edetic Acid; Humans; Physicians; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Stroke; Surveys and Questionnaires

2020
Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.
    JAMA, 2013, Mar-27, Volume: 309, Issue:12

    Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke

2013
Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).
    JAMA, 2013, Mar-27, Volume: 309, Issue:12

    Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke

2013
Chelation therapy and cardiovascular outcomes.
    JAMA, 2013, Jul-24, Volume: 310, Issue:4

    Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke

2013
Chelation therapy and cardiovascular outcomes.
    JAMA, 2013, Jul-24, Volume: 310, Issue:4

    Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke

2013
Chelation therapy and cardiovascular outcomes--in reply.
    JAMA, 2013, Jul-24, Volume: 310, Issue:4

    Topics: Angina Pectoris; Chelating Agents; Edetic Acid; Female; Humans; Male; Myocardial Infarction; Stroke

2013
Subacute Stroke Mimicking Cerebral Metastasis in 68Ga-PSMA-HBED-CC PET/CT.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:10

    Topics: Aged; Antigens, Surface; Brain Neoplasms; Diagnosis, Differential; Edetic Acid; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Stroke

2016
ALOX5AP gene and the PDE4D gene in a central European population of stroke patients.
    Stroke, 2005, Volume: 36, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 5-Lipoxygenase-Activating Proteins; Aged; Alleles; Carrier Proteins; Case-Control Studies; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Edetic Acid; Europe, Eastern; Female; Gene Frequency; Genetic Markers; Genotype; Haplotypes; Humans; Iceland; Ischemia; Linkage Disequilibrium; Magnetic Resonance Imaging; Male; Membrane Proteins; Microsatellite Repeats; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Regression Analysis; Risk; Risk Factors; Sex Factors; Stroke

2005